Wassermann investigation centre

Alfa Wassermann was a prominent Italian pharmaceutical company founded in 1948, best known for its research and development of original molecules, most notably rifaximin. The company focused on therapeutic areas such as gastroenterology, vascular health, and orthopedics. In 2015, Alfa Wassermann merged with Sigma-Tau to form Alfasigma, one of the largest pharmaceutical groups in Italy. The company's legacy includes a strong portfolio of prescription and over-the-counter medicines marketed globally, including brands like Normix and Vessel Due F. The 'Wassermann Investigation Centre' refers to the company's historical R&D operations, which were instrumental in its clinical successes. Today, its operations are fully integrated into the Alfasigma organization.